Recommended Citation
Robin C. Feldman, David A. Hyman, W. Nicholson Price II, and Mark J. Ratain,
Negative Innovation: When Patents Are Bad for Patients, 39
Nature Biotech.
914
(2021).
Available at: https://repository.uclawsf.edu/faculty_scholarship/1850
Publication Date
2021
Abstract
Incentives in patent law have driven innovation into spaces that are affirmatively harmful to patients, and patentees are discouraged from taking steps to improve the product so as to prevent adverse health outcomes.
Document Type
Article
Publication Title
Nature Biotechnology